GB8308056D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB8308056D0 GB8308056D0 GB838308056A GB8308056A GB8308056D0 GB 8308056 D0 GB8308056 D0 GB 8308056D0 GB 838308056 A GB838308056 A GB 838308056A GB 8308056 A GB8308056 A GB 8308056A GB 8308056 D0 GB8308056 D0 GB 8308056D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08308056A GB2118176B (en) | 1982-03-24 | 1983-03-24 | Pharmaceutical compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8208608 | 1982-03-24 | ||
GB08308056A GB2118176B (en) | 1982-03-24 | 1983-03-24 | Pharmaceutical compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8308056D0 true GB8308056D0 (en) | 1983-05-05 |
GB2118176A GB2118176A (en) | 1983-10-26 |
GB2118176B GB2118176B (en) | 1985-12-04 |
Family
ID=26282349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08308056A Expired GB2118176B (en) | 1982-03-24 | 1983-03-24 | Pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2118176B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
GB8325494D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
US4912118A (en) * | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
USRE34313E (en) * | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
US5177068A (en) * | 1984-04-19 | 1993-01-05 | National Research Development Corporation | Pharmaceutical compositions |
DE3585869D1 (en) * | 1984-10-30 | 1992-05-21 | Otsuka Pharma Co Ltd | COMPOSITION FOR INCREASING ANTI-CANCER ACTIVITY OF AN ANTI-CANCER CONNECTION. |
US5789426A (en) * | 1995-01-20 | 1998-08-04 | Cornell Research Foundation, Inc. | Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
ATE299135T1 (en) * | 1995-09-29 | 2005-07-15 | Novartis Pharma Gmbh | HYDROXYPYRIDINONE |
GB9625638D0 (en) * | 1996-12-10 | 1997-01-29 | Cenes Ltd | Therapeutic antioxidants for alzheimer's diease |
GR1003358B (en) * | 1997-03-12 | 2000-04-10 | �.�. �������� �����������������-����������-������������... | Process for producing 1,2-dimethyl-3-hydroxypyrid-4-one |
CA2313270C (en) * | 2000-06-30 | 2011-09-13 | Apotex Inc. | Use of deferiprone in treating and preventing iron-induced cardiac disease |
-
1983
- 1983-03-24 GB GB08308056A patent/GB2118176B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB2118176A (en) | 1983-10-26 |
GB2118176B (en) | 1985-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8326565D0 (en) | Pharmaceutical compositions | |
GB8327612D0 (en) | Pharmaceutical compositions | |
GB2136807B (en) | Pharmaceutical compositions | |
EP0138540A3 (en) | Pharmaceutical compositions | |
ZA834074B (en) | Pharmaceutical composition | |
GB2136806B (en) | Pharmaceutical compositions | |
ZA833781B (en) | Pharmaceutical compositions | |
EP0093551A3 (en) | Pharmaceutical composition | |
CY1503A (en) | Pharmaceutical compositions | |
GB2118176B (en) | Pharmaceutical compositions | |
GB2117766B (en) | Pharmaceutical compositions | |
PT77323A (en) | Pharmaceutical compositions | |
GB8429749D0 (en) | Pharmaceutical compositions | |
GB8313814D0 (en) | Pharmaceutical compositions | |
GB8329700D0 (en) | Anti-haemophilic pharmaceutical composition | |
DE3377696D1 (en) | Pharmaceutical compositions | |
US4594359B1 (en) | Pharmaceutical compositions | |
GB8328896D0 (en) | Pharmaceutical composition | |
EP0136006A3 (en) | Pharmaceutical compositions | |
GB2114001B (en) | Nasel pharmaceutical compositions | |
GB8305028D0 (en) | Pharmaceutical compositions | |
GB8330810D0 (en) | Pharmaceutical compositions | |
GB8314736D0 (en) | Pharmaceutical compositions | |
GB8332653D0 (en) | Pharmaceutical composition | |
GB8331068D0 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
7732 | Case decided by the comptroller ** patent revoked (sect. 73(2)/1977) |